Navigation Links
K-V Pharmaceutical Comments on ACOG and SMFM Information Update Regarding 17-Alpha Hydroxyprogesterone Caproate - FDA-Approved Makena™ and Compounded 17P
Date:10/13/2011

munity, and patient co-pays for Makena are averaging approximately $12 per injection.  

For details regarding the Makena financial assistance program for clinically-eligible patients, please visit www.makena.com.

The full text of the ACOG and SMFM information update is available at www.acog.org.

About K-V Pharmaceutical Company

K-V Pharmaceutical Company is a specialty branded pharmaceutical company with a primary focus in the area of women's healthcare.   As such, we are committed to advancing the health of women across all the stages of their lives.

For further information about K-V Pharmaceutical Company, please visit the Company's corporate Website at www.kvpharmaceutical.com.

Cautionary Note Regarding Forward-looking Statements

This press release contains various forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995 (the "PSLRA") and that may be based on or include assumptions concerning the operations, future results and prospects of the Company. Such statements may be identified by the use of words like "plan," "expect," "aim," "believe," "project," "anticipate," "commit," "intend," "estimate," "will," "should," "could," "potential" and other expressions that indicate future events and trends.

All statements that address expectations or projections about the future, including without limitation, statements about product development, product launches, regulatory approvals, governmental and regulatory actions and proceedings, market position, acquisitions, sale of assets, revenues, expenditures, resumption of manufacturing and distribution of products and the impact of the recall and suspension of shipments on revenues, and other financial results, are forward-looking statements.


'/>"/>
SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... DIEGO y PARÍS, 24 de mayo ... VOLC ), un destacado desarrollador y fabricante de ... mejorar la diagnosis y tratamiento de la enfermedad ... preliminares del ensayo ADVISE ( Ad enosine ... E valuation) II durante la sesión de ...
(Date:5/23/2013)... May 23, 2013 Amgen (NASDAQ: AMGN ... Annual  Healthcare Conference on Thursday, May 30, 2013, at the ... at 9:20 a.m. Eastern Daylight Time. Arvind Sood ... present at the conference. Live audio of the presentation can ... www.amgen.com , under Investors. A replay of the webcast will ...
(Date:5/23/2013)... Nephros, Inc. (OTC Bulletin Board: ... develops and sells high performance liquid purification ultrafilters, announced ... addition, the concurrent temporary reduction in exercise price for ... 2013. Nephros estimates that it will receive ... A portion of the proceeds will be used for ...
Breaking Medicine Technology:Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... 13, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ... CSKI ), a leading fully integrated pharmaceutical company ... ("PRC"), today announced that it held its 2011 Annual ... 2011, in Harbin, PRC. At the Annual ...
... 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") ... in-vitro diagnostic ("IVD") company, today announced that China,s State ... Company,s real-time PCR-based V-Ki-ras2 Kirsten rat sarcoma viral oncogene ... companion diagnostic test for the use of a targeted ...
Cached Medicine Technology:China Sky One Medical, Inc. Elects Board Directors at its Annual Shareholders Meeting 2China Medical Technologies Receives SFDA Approval for its PCR-based KRAS Assay for Colorectal Cancer Targeted Drug 2
(Date:5/23/2013)... 23, 2013 Today, Zane Benefits, Inc. ... . Zane Benefits, which provides comprehensive and flexible alternatives ... in defined contribution plans and health ... common question from employees is “does my employer have ... not necessarily. The health care reform law, called the ...
(Date:5/23/2013)... 2013 Da Vinci surgical robot maker ... in Washington State May 23, according to Bloomberg.* The ... surgical robot lawsuits , expresses disappointment in the ruling ... to not read a single verdict as representative of ... Fred E. Taylor v. Intuitive Surgical Inc.; 09-2-03136-5, Superior ...
(Date:5/23/2013)... modified version of the polio virus might one ... Scientists at Duke Cancer Institute said the ... engineered form of the virus that is harmless ... therapy shows promise in the treatment of glioblastoma, ... said. "These early results are intriguing," principal ...
(Date:5/23/2013)... Ohio (May 23, 2013)Don,t doubt it when a woman ... time remembering things. A new study published online in ... Menopause Society (NAMS), helps confirm with objective tests that ... , In the past, some studies showed that hot ... Other studies showed that, even though there was a ...
(Date:5/23/2013)... May 23, 2013 Susquehanna Health ... offering a comprehensive babysitting training course for adolescents age ... developed by Indianapolis pediatrician Dr. Patricia Keener after a ... of an adult sitter who didn’t know how to ... development program with a medical basis that aims to ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on the Employer Mandate 2Health News:Zane Benefits Publishes New Information on the Employer Mandate 3Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2Health News:Modified Polio Virus May Help Fight Brain Tumors, Study Suggests 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 2Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 3
... in GI and Endoscopy Nursing at SGNA 36th Annual ... Nurses and Associates, Inc. (SGNA) is proud to honor ... awards that recognize their dedication to the field and ... distinguished awards represent the best in GI and endoscopy ...
... MMR Information Systems, Inc. (OTC Bulletin Board: MMRF) (the ... acquired its subsidiary MyMedicalRecords, Inc. ("MMR") in January ... to license certain of the Company,s rights relating to ... proposal were not announced.In June 2007, prior to the ...
... Intermountain Medical Center in Salt Lake City believe that ... a fairly common heart rhythm disorder, and Alzheimer,s disease, ... a study presented Friday, May 15, at "Heart Rhythm ... Society in Boston, researchers unveiled findings from the study ...
... Inc. (Nasdaq: ENDO ), an innovative medical ... technologies used by urologists and interventional radiologists for tissue ... quarter ended March 31, 2009. Highlights of the ... strong margins.Total revenues for the first quarter of 2009 ...
... Top Talent in Non-Profit Sector , ... ... of the talented businesswomen in the non-profit sector, Menttium Corporation, ... 100® leadership development program. , , ,Menttium 100 Program participants ...
... "EXQ") today announced the launch of a new research grant program, ... , ... (PRWEB) May 15, 2009 -- Exiqon A/S ... research grant program, open to researchers from academic and non-profit institutions ...
Cached Medicine News:Health News:SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards 2Health News:SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards 3Health News:SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards 4Health News:MMR Information Systems, Inc. Receives Licensing Proposal Involving the Company's Anti-CD20 Antibodies 2Health News:MMR Information Systems, Inc. Receives Licensing Proposal Involving the Company's Anti-CD20 Antibodies 3Health News:Study makes first connection between heart disorder and Alzheimer's disease 2Health News:Endocare Reports 2009 First Quarter Financial Results 2Health News:Endocare Reports 2009 First Quarter Financial Results 3Health News:Endocare Reports 2009 First Quarter Financial Results 4Health News:Endocare Reports 2009 First Quarter Financial Results 5Health News:Endocare Reports 2009 First Quarter Financial Results 6Health News:Endocare Reports 2009 First Quarter Financial Results 7Health News:Endocare Reports 2009 First Quarter Financial Results 8Health News:Endocare Reports 2009 First Quarter Financial Results 9Health News:Endocare Reports 2009 First Quarter Financial Results 10Health News:Endocare Reports 2009 First Quarter Financial Results 11Health News:Menttium Offers Scholarship Award to Businesswomen Leaders 2Health News:Exiqon Announces New Grant Program for MicroRNA Research 2
... The Medtronic Diagnostic Workstation is ... your gastrointestinal function testing needs. ... by allowing you to expand ... the consistency and reliability of ...
... using multi-channel catheters with secondary sensors placed ... catheter-based pH test also provides information about ... in the stomach or proximal esophageal acid ... pulmonary symptoms. Ability to record pH simultaneously ...
... Oxoid Pylori Test is ... for the qualitative detection of ... serum as an aid in ... H. pylori. The product is ...
... The Paragon CZE 2000 Capillary ... automate clinical serum protein electrophoresis (SPE), ... (IFE/s) for fast and accurate analysis. ... almost no sample preparation and no ...
Medicine Products: